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Erythema elevatum diutinum 
is a rare chronic leukocytoclastic 
vasculitis of unknown etiology, 
characterized by red to reddish 
brown or purple papules and plaques, 
predominantly on the extensor 
surfaces of the extremities. It may be 
associated with various pathologies 
and the diagnosis is based on clinical 
and histopathological findings. The 
treatment includes dapsone and 
sulfonamides, first-line therapies, and 
other options such as niacinamide, 
tetracycline, colchicine, chloroquine 
and corticosteroids. We describe the 
case of a 65-year-old male patient 
with an unusual single lesion.
Case RepoRt
A 65-year-old caucasian male 
smoker came to our clinic with a 
3-month history of a pruritic lesion on 
the dorsum of the hand. Examination 
revealed a red-purple indurated 
plaque with crusts on the dorsum of 
the right hand (figure 1).  A skin biopsy 
was performed and histology 
revealed chronic psoriasiform 
dermatitis with verrucous 
hyperplasia, papillary fibrosis and 
a predominantly eosinophilic and 
neutrophilic infiltrate (figure 2). 
These findings were consistent with 
erythema elevatum diutinum. The 
investigation for associated disorders 
or comorbidities was negative. 
Initially, the patient was treated with 
intralesional corticosteroids with low 
response. Therefore, oral dapsone 
100 mg daily was begun, showing 
immediate satisfactory results, with 
only residual post-inflammatory 
hyperpigmentation (figure 3).
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Erythema elevatum diutinum is a rare chronic leukocytoclastic vasculitis of unknown 
etiology. Lesions are usually asymptomatic, although burning and itchiness can 
occur. The typical clinical presentation is characterized by persistent, symmetrical, 
papules and nodules that may coalesce to form larger nodules or plaques. It may 
be associated with various pathologies and the diagnosis is based on clinical 
and histopathological findings. Treatment is based on the use of dapsone and 
sulfonamides, first-line therapies, and other options such as niacinamide, tetracycline, 
colchicine, chloroquine and corticosteroids. We describe the case of a 65-year-old 
male patient that presented a single lesion on the dorsum of the hand, an unusual 
clinical presentation.
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Figure 1: A red-purple indurated plaque with crusts on the dorsum of the right hand.
Figure 2: Histology revealing a chronic psoriasiform dermatitis with verrucous hyperplasia, 
papilar fibrosis and a predominantly eosinophilic and neutrophilic infiltrate.
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Comments
Erythema elevatum diutinum (EED) was first 
described in 1894. Since then, almost 250 cases 
have been reported in the literature (1). EED is a 
rare chronic leukocytoclastic vasculitis, which is 
more often seen in patients in the fourth through 
the six decade (2,3). It affects equally both genders 
and may be associated with many disorders. The 
cause of EED is unknown, but it is presumed to 
be related to vascular immune complex deposition. 
(2,4,5)
The typical clinical presentation is characterized 
by persistent, symmetrical, firm, tender, red to 
reddish brown or purple papules and nodules that 
may coalesce to form larger nodules or plaques, 
predominantly on the extensor surface of the 
extremities and near the joints (hands, elbows, 
knees) (2,5-7). Lesions are usually asymptomatic, 
although burning and itchiness can occur (3). 
Occurrences at atypical sites have been reported, 
including trunk, retro-auricular, palmar and plantar 
lesions (2,8). Joint pain is the most common 
systemic symptom, observed in up to 40% of the 
cases (8). Delay in diagnosis can occur in unusual 
presentations and atypical clinical forms are usually 
diagnosed only after histopathological analysis 
(10).
The differential diagnosis of EED is quite 
broad and includes Sweet’s syndrome, granuloma 
annulare, sarcoidosis, pseudolymphoma, Wegener’s 
granulomatosis and multicentric reticulohistiocytosis. 
The histopathology of early lesions begin with 
leukocytoclastic vasculitis, polymorphonuclear 
cell infiltrate and fibrin deposition in the superficial 
and mid-dermis. Mature lesions demonstrate 
a combination of granulation response or skin 
healing combined with a proliferation of dermal 
spindle cells, with or without multinucleate giant 
cells (2). The diagnosis of erythema elevatum 
diutinum is based on the characteristic clinical 
lesion, histopathological findings and laboratory 
investigations (2).
In EED patients, it is important to exclude 
association with other disorders such as 
infectious diseases (streptococci, hepatitis B, 
HIV), certain malignancies (glioma, squamos 
cell carcinoma, breast carcinoma), autoimmunity 
(rheumatoid arthritis, Crohn’s disease, Wegener’s 
granulomatosis) and hematological abnormalities 
(myelodysplasia, multiple myeloma, lymphoma, 
paraproteinemias). For such purpose, a laboratory 
investigation should be performed: complete 
blood count, electrolytes, creatinine, liver function 
tests, rheumatoid factor, hemossedimentation 
rate, reactive C protein, urinary and serum protein 
Figure 3: Patients skin lesion after oral dapsone 100 mg daily, showing satisfactory response, with only residual 
post-inflammatory hyperpigmentation.





electrophoresis, Bence-Jones protein, hepatitis 
B, syphilis and HIV serologies, anti-endomysial 
antibody, anti-DNAse and antistreptolysin O 
(2,10). Even though screening is normal, long term 
monitoring is necessary to detect hematologic 
disorder early (1).
The treatment of EED is difficult because of 
its chronic and recurrent course. When possible, 
treatment of the underlying cause should be targeted. 
Dapsone and sulphonamides are first-line treatments 
for EED (2,11,12). Other employed therapies include 
tetracycline, colchicine, niacinamide, chloroquine 
and corticosteroids (2,9). With the regression of the 
lesions, residual hyperpigmentation with occasional 
atrophy is commonly seen (9).
The clinical findings in our case are unusual, 
since the case presented with a single lesion. 
The histopathological findings and the excellent 
response to dapsone are compatible with the 
diagnosis of EED. EED can be clinically confused 
with other disorders; an unusual presentation and 
its low incidence favor a delay in diagnosis and, 
consequently, an evolution to chronicity, when 
lesions are less responsive to medical therapy. 
This case reports an unusual clinical presentation 
with a single lesion, which has rarely been reported 
in the literature. 
1. El Fekih N, Belgith I, Fazaa B, 
Remmah S, Zéqlaoui F, Zermani R, et 
al. Erythema elevatum diutinum: an 
“idiopathic” case. Dermatol Online J. 
2011;17:7.
2. Gibson LE, el-Azhary RA. Erythema 
elevatum diutinum. Clin Dermatol. 
2000;18:295-9.
3. Costa FB, Duquia RP, Souza PR, 
Vettorato G, Almeida HL. Caso para 
diagnóstico. An Bras Dermatol. 
2009;84:429-30.
4. High WA, Hoang MP, Stevens K, 
Cockerell CJ. Late-stage nodular 
erythema elevatum diutinum. J Am 
Acad Dermatol. 2003;49:764-7.
5. Jiao T, Wang M, Zhu X. A case 
of erythema elevatum diutinum 
associated with peripheral ulcerative 
keratitis. Australas J Dermatol. 
2012;53:78-80.
6. Chowdhury MM, Inaloz HS, Motley 
RJ, Knight AG. Erythema elevatum 
diutinum and IgA paraproteinaemia: 
"a preclinical iceberg". Int J Dermatol. 
2002;41:368-70.
7. Hansen U, Haerslev T, Knudsen B, 
Jacobsen GK. Erythema elevatum 
diutinum: case report showing 
an unusual distribution. Cutis. 
1994;53:124-6.
8. Barzegar M, Davatchi CC, Akhyani 
M, Nikoo A, Daneshpazhooh M, 
Farsinejad K. An atypical presentation 
of erythema elevatum diutinum 
involving palm and soles. Int J 
Dermatol. 2009;48:73-5. 
9. Rosa DJ, Machado RF, Fraga RO, 
Scotton AS, Souza VA, Fernandes 
B. Erithema elevatum diutinum as 
a differential diagnosis of rheumatic 
diseases: case report. Rev Bras 
Reumatol. 2012;52:291-4.
10. Ly H, Black MM. Atypical presentation 
of erythema elevatum diutinum. 
Australas J Dermatol. 2005;46:44-6.
11. Vollum DI. Erythema elevatum 
diutinum - Vesicular lesions and 
sulfone response. Br J Dermatol. 
1968;80:178-83.
12. Wilkinson SM, English JS, Smith 
NP, Wilson-Jones E, Winkelmann 
RK. Erythema elevatum diutinum: a 
clinicopathological study. Clin Exp 
Dermatol. 1992;17:87-93.
